Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsSam Pearce is recorded as CFO at Jazz Pharmaceuticals plc (JAZZ). Sam Pearce has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Jazz Pharmaceuticals plc on November 2, 2026. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
“It has been an absolute privilege to lead this exceptional commercial team during a transformative period of growth to Jazz.”
“Well, I mean, I think I'm first and foremost delighted with the way the teams are executing on the opportunities that we have across our entire portfolio at the moment.”
“Our commercial teams delivered another impressive quarter of revenue, with 16% growth across the portfolio and double-digit growth from each of our key promoted brands.”
“Our commercial team delivered strong results across JAZZ's portfolio, with momentum from our 2025 launches and coordinated execution continuing into 2026. I'll begin on slide 7 with sleep.”
“I'm pleased to share the strong commercial execution we delivered across our diversified portfolio in 2025.”
Biotechnology · Healthcare
CFO
